天麻素对2型糖尿病大鼠种植体周围骨组织的影响
研究将40只SD大鼠分为对照组、糖尿病组和天麻素组,在双侧胫骨干骺端植入纯钛种植体。天麻素组每日灌胃13.6 mg/kg天麻素,术后4、8周检测氧化应激指标、凋亡蛋白表达及显微CT骨参数。结果显示天麻素组血糖、丙二醛低于糖尿病组,SOD活力、bcl-2表达及部分骨参数高于糖尿病组。
要点
- 天麻素组术后各时间点血糖均显著低于糖尿病组,但两组均高于对照组。
- 天麻素组血清丙二醛低于糖尿病组,SOD活力高于糖尿病组。
- 天麻素组bcl-2表达高于糖尿病组,bax表达低于糖尿病组。
核心结论
- 天麻素可在2型糖尿病大鼠模型中发挥降糖、改善氧化应激、保护骨组织免受凋亡,促进种植体周围骨组织生成的作用。
研究设计与样本
- 40只5周龄SD大鼠分为对照组(n=10)和造模组(n=30),造模组高脂高糖饲料喂养4周后腹腔注射35 mg/kg链脲佐菌素建立2型糖尿病模型。
- 造模成功大鼠分为糖尿病组(n=10)和天麻素组(n=10),所有大鼠双侧胫骨干骺端各植入1枚纯钛种植体。
- 天麻素组每日灌胃13.6 mg/kg天麻素,对照组和糖尿病组给予同等剂量生理盐水;术后4、8周每组每个时间点5只取材检测。
主要发现
- 术后2、4、6、8周天麻素组血糖分别为(12.98±2.53)、(13.64±1.96)、(14.58±3.40)和(12.84±2.82)mmol/L,均显著低于相同时间点糖尿病组的(20.97±2.27)、(17.94±3.76)、(23.66±2.90)和(21.22±2.67)mmol/L(P<0.017),但两组血糖均显著高于对照组(P<0.017)。
- 术后4和8周天麻素组丙二醛浓度分别为(5.21±1.60)和(3.47±1.17)nmol/ml,均显著低于相同时间点糖尿病组的(11.42±5.11)和(7.31±1.37)nmol/ml(P<0.017);天麻素组SOD活力分别为(42.89±6.00)和(53.12±9.73)U/ml,均显著高于相同时间点糖尿病组的(27.09±6.11)和(32.08±2.97)U/ml(P<0.017)。
- 术后4和8周天麻素组种植体周围骨组织bcl-2蛋白表达均显著高于相同时间点糖尿病组(P<0.017),bax蛋白表达均显著低于相同时间点糖尿病组(P<0.017)。
- 术后4周天麻素组BV/TV、Conn.D、Tb.N和Tb.Th均显著大于糖尿病组(P<0.017),Tb.sp与糖尿病组差异无统计学意义(P>0.017)。
- 术后8周天麻素组BV/TV、Tb.N均显著大于糖尿病组(P>0.017),Conn.D与糖尿病组差异无统计学意义(P>0.017);3组Tb.Th、Tb.sp差异均无统计学意义(F=1.23,P=0.331;F=1.19,P=0.340),HE染色显示天麻素组骨小梁形态结构比糖尿病组更好。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To study the effect of gastrodin on oxidative stress and bone tissue around implants in type 2 diabetes mellitus rats (T2DM), so as to provide therapeutic basis for the problems of poor osseointegration and long repair period of implants in type 2 diabetic patients, to provide the basis for the development of new therapeutic drugs. Methods: Forty SD rats aged 5 weeks were divided into control group (n=10) and model group (n=30). The model group was fed with high glycolipid diet for 4 weeks and injected with 35 mg/kg streptozocin. The T2DM were divided into diabetic group (n=10) and gastrodin group (n=10). Pure screw titanium implants were placed in the metaphysis of both tibia. Rats in gastrodin group were given gastrodin 13.6 mg/kg everyday, while the control group and diabetic group were given the same dose of saline solution. Blood glucose was measured every two weeks after operation in all rats. After 4 and 8 weeks, the contents of serum malondialdehyde (MDA) and superoxide dismutase (SOD) were measured to analyze the oxidative stress level in rats. The expression of anti-apoptosis protein [B cell lymphoma/lewkmia-2 (bcl-2)]and apoptosis protein [bcl-2-associated X protein (bax)] was analyzed by immunohistochemistry. HE staining and micro-CT scanning were used to analyze the osseointegration around the implants. Results: The blood glucose of gastrodin [(12.98±2.53), (13.64±1.96), (14.58±3.40) and (12.84±2.82) mmol/L] were significantly lower than that of diabetic group [(20.97±2.27), (17.94±3.76), (23.66±2.90) and (21.22±2.67) mmol/L] at corresponding time point (P<0.017). Four and 8 weeks following surgery, the MDA concentration in gastrodin group [(5.21±1.60) and (3.47±1.17) nmol/ml] was significantly lower than that in diabetic group [(11.42±5.11) and (7.31±1.37) nmol/ml] at the corresponding time points (P<0.017), while SOD activity in gastrodin group [(42.89±6.00) and (53.12±9.73) U/ml] was significantly higher than those in diabetic group [(27.09±6.11) and (32.08±2.97) U/ml] at the corresponding time points (P<0.017). Immunohistochemistry showed that the bcl-2 expression in gastrodin group was significantly higher than that in diabetic group at 4 and 8 weeks following surgery (P<0.017), while the bax expression in gastrodin group was significantly lower than that in diabetic group (P<0.017). Four weeks after surgery, the bone volume/tissue volume (BV/TV), connection density (Conn.D), trabecular number (Tb.N), trabecular thickness (Tb.Th) in gastrodin group were significantly higher than those in diabetic group (P<0.017). There was no significant difference in trabecular separation/spacing (Tb.sp) between gastrodin group and diabetic group (P<0.017). Eight weeks after surgery, the BV/TV, Tb.N in gastrodin group were significantly higher than those in the diabetic group (P<0.017). There was no significant difference in Conn.D between gastrodin group and diabetic group (P<0.017). There was no significant difference in Tb.Th and Tb.sp in three groups (P<0.017). The trabecular structure in gastrodin group was better than that in diabetic group by HE staining. Conclusions: Gastrodin can decrease blood glucose, improve oxidative stress, protect bone tissue from apoptosis and promote bone formation around implants in T2DM. 目的: 探讨天麻素对2型糖尿病大鼠体内氧化应激及种植体周围骨组织的影响,以期为2型糖尿病患者种植体骨结合不良问题的新药开发提供依据。 方法: 40只5周龄SD大鼠分为对照组(10只)和造模组(30只)。造模组高脂高糖饲料喂养4周后,腹腔注射35 mg/kg剂量的链脲佐菌素行2型糖尿病造模。造模成功大鼠分为糖尿病组和天麻素组(每组各10只)。所有大鼠双侧胫骨干骺端各植入1枚纯钛种植体。术后每日天麻素组大鼠灌胃13.6 mg/kg天麻素,对照组、糖尿病组给予同等剂量生理盐水。术后每两周检测血糖。术后4、8周(每组每个时间点5只)取材,检测各组大鼠血清丙二醛和超氧化物歧化酶(superoxide dismutase,SOD)含量;免疫组化法分析抗凋亡蛋白[B细胞淋巴瘤/白血病-2(B cell lymphoma/lewkmia-2,bcl-2)蛋白]与凋亡蛋白[bcl-2关联X(bcl-2-associated X,bax)蛋白]表达情况;HE染色及显微CT扫描分析种植体周围骨结合情况,包括骨体积分数(bone volume/tissue volume,BV/TV)、连接密度(connection density,Conn.D)、骨小梁数量(trabecular number,Tb.N)和骨小梁厚度(trabecular thickness,Tb.Th)和骨小梁分离度(trabecular separation/spacing,Tb.sp)。 结果: 术后2、4、6、8周天麻素组血糖值[(12.98±2.53)、(13.64±1.96)、(14.58±3.40)和(12.84±2.82)mmol/L]均比相同时间点糖尿病组[(20.97±2.27)、(17.94±3.76)、(23.66±2.90)和(21.22±2.67)mmol/L]显著降低(P<0.017),但两组血糖均显著高于对照组(P<0.017)。术后4和8周天麻素组丙二醛浓度[(5.21±1.60)和(3.47±1.17)nmol/ml]均显著小于相同时间点糖尿病组[(11.42±5.11)和(7.31±1.37)nmol/ml](P<0.017);天麻素组SOD活力[(42.89±6.00)和(53.12±9.73)U/ml]均显著大于相同时间点糖尿病组[(27.09±6.11)和(32.08±2.97)U/ml](P<0.017)。免疫组化染色显示,术后4和8周天麻素组种植体周围骨组织bcl-2蛋白表达均显著大于相同时间点糖尿病组(P<0.017);bax蛋白表达均显著小于相同时间点糖尿病组(P<0.017)。术后4周,天麻素组BV/TV、Conn.D、Tb.N和Tb.Th均显著大于糖尿病组(P<0.017);Tb.sp与糖尿病组差异无统计学意义(P>0.017)。术后8周,天麻素组BV/TV、Tb.N均显著大于糖尿病组(P>0.017),天麻素组Conn.D与糖尿病组差异无统计学意义(P>0.017);3组Tb.Th、Tb.sp差异均无统计学意义(F=1.23,P=0.331;F=1.19,P=0.340)。HE染色显示,天麻素组骨小梁形态结构比糖尿病组更好。 结论: 天麻素可在2型糖尿病大鼠模型中发挥降糖、改善氧化应激、保护骨组织免受凋亡,促进种植体周围骨组织生成的作用。.
引用
- Zhang JY, Li FL, Wang H, et al. [Effect of gastrodin on bone tissue around implants in type 2 diabetic rats]. Zhonghua Kou Qiang Yi Xue Za Zhi. 2022. PMID: 36097941. doi:10.3760/cma.j.cn112144-20220129-00036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。